Format

Send to

Choose Destination
Circulation. 2018 Oct 9;138(15):1502-1504. doi: 10.1161/CIRCULATIONAHA.118.036069.

Alirocumab's Price Reduction.

Dhruva SS1,2, Ross JS1,3,4,5, Desai NR6,5.

Author information

1
National Clinician Scholars Program (S.S.D., J.S.R.), Yale University, New Haven, CT.
2
Veterans Affairs Connecticut Healthcare System, West Haven (S.S.D.).
3
Section of General Internal Medicine (J.S.R.), Yale University, New Haven, CT.
4
Department of Internal Medicine, Yale School of Medicine, and Department of Health Policy and Management, Yale School of Public Health (J.S.R.), Yale University, New Haven, CT.
5
Center for Outcomes Research and Evaluation, Yale New Haven Hospital, CT (J.S.R., N.R.D.).
6
Section of Cardiovascular Medicine (N.R.D.), Yale University, New Haven, CT.

KEYWORDS:

cardiovascular diseases; cost-benefit analysis; costs and cost analysis; insurance, health, reimbursement; outcome and process assessment (health care)

Supplemental Content

Full text links

Icon for Atypon
Loading ...
Support Center